Inhibition of FMLP-stimulated neutrophil chemiluminescence by blood platelets increased in the presence of the serotonin-liberating drug chloroquine

Thrombosis Research

Volumn 109, Issue 5-6, 2003, Pages 293-298

  Jančinová, Viera ^a   Drábiková, Katarína ^a   Nosál, Radomír ^a   Petríková, Margita ^a   Číž, Milan ^b   Lojek, Antonín ^b   Danihelová, Edita ^c  

^a INSTITUTE OF EXPERIMENTAL PHARMACOLOGY AND TOXICOLOGY   (Slovakia)

^b INSTITUTE OF BIOPHYSICS   (Czech Republic)

^c Inst Haematol/Transfusiology   (Slovakia)

Author keywords

Blood platelets; Chemiluminescence; Chloroquine; FMLP; Neutrophils; Serotonin

Indexed keywords

AMINE; CALCIUM IONOPHORE; CHLOROQUINE; FORMYLMETHIONYLLEUCYLPHENYLALANINE; LUMINOL; REACTIVE OXYGEN METABOLITE; SEROTONIN;

ADULT; ARTICLE; CELL ASSAY; CELL LEVEL; CELL STIMULATION; CELLULAR PARAMETERS; CHEMOLUMINESCENCE; CONCENTRATION (PARAMETERS); DRUG MECHANISM; FLUOROMETRY; HUMAN; HUMAN CELL; MALE; NEUTROPHIL; NORMAL HUMAN; PRIORITY JOURNAL; SAMPLING; SEROTONIN RELEASE; SUPERNATANT; THROMBOCYTE;

EID: 0038006802     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0049-3848(03)00239-1     Document Type: Article

References (41)

1. Geerts L., Jorens P.G., Willems J., De Ley M., Slegers H. Natural inhibitors of neutrophil function in acute respiratory distress syndrome. Crit. Care Med. 29:2001;1920-1924.
2. Jordan J.E., Zhao Z.-Q., Vinten-Johansen J. The role of neutrophils in myocardial ischemia-reperfusion injury. Cardiovasc. Res. 43:1999;860-878.
3. Heinzelmann M., Mercer-Jones M.A., Passmore J.C. Neutrophils and renal failure. Am. J. Kidney Dis. 34:1999;384-399.
4. Mur E., Zabernigg A., Hilbe W., Eisterer W., Halder W., Thaler J. Oxidative burst of neutrophils in patients with rheumatoid arthritis: influence of various cytokines and medication. Clin. Exp. Rheumatol. 15:1997;233-237.
5. Kountouras J., Chatzopoulos D., Zavos C. Reactive oxygen metabolites and upper gastrointestinal diseases. Hepato-Gastroenterol. 48:2001;743-751.
6. Akopov S.E., Simonian N.A., Grigorian G.S. Dynamics of polymorphonuclear leukocyte accumulation in acute cerebral infarction and their correlation with brain tissue damage. Stroke. 27:1996;1739-1743.
7. Serrano C.V., Ramires J.A.F., Venturinelli M., Arie S., D'Amico E., Zweier J.L.et al. Coronary angioplasty results in leukocyte and platelet activation with adhesion molecule expression. Evidence of inflammatory responses in coronary angioplasty. J. Am. Coll. Cardiol. 29:1997;1276-1283.
8. Jaremo P., Hansson G., Nilsson O. Elevated inflammatory parameters are associated with lower platelet density in acute myocardial infarctions with ST-elevation. Thromb. Res. 100:2000;471-478.
9. Reinisch C.M., Dunzendorfer S., Pechlaner C., Ricevuti G., Wiedermann C.J. The inhibition of oxygen radical release from human neutrophils by resting platelets is reversed by administration of acetylsalicylic acid or clopidogrel. Free Radic. Res. 34:2001;461-466.
10. Lösche W., Temmler U., Redlich H., Vickers J., Krause S., Spangenberg P. Inhibition of leukocyte chemiluminescence by platelets: role of platelet-bound fibrinogen. Platelets. 12:2001;15-19.
11. Lösche W., Dressel M., Krause S., Redlich H., Spangenberg P., Heptinstall S. Contact-induced modulation of neutrophil elastase secretion and phagocytic activity by platelets. Blood Coagul. Fibrinolysis. 7:1996;210-213.
12. Del Principe D., Menichelli A., Di Giulio S., De Matteis W., Giordani M., Pentassuglio A.M.et al. Stimulated platelets release factor(s) affecting the in vitro response of human polymorphonuclear cells. J. Leukoc. Biol. 48:1990;7-14.
13. Drábiková K., Jančinová V., Nosál' R., Danihelová E. Human blood platelets, PMN leukocytes and their interactions in vitro. Responses to selective and non-selective stimuli. Gen. Physiol. Biophys. 19:2000;393-404.
14. Jančinová V., Nosál' R., Drábiková K., Danihelová E. Cooperation of chloroquine and blood platelets in inhibition of polymorphonuclear leukocyte chemiluminescence. Biochem. Pharmacol. 62:2001;1629-1636.
15. 2). Thromb. Res. 105:2002;339-345.
16. 1-antagonist dithiaden in human PMN leukocytes. Free Radic. Res. 36:2002;975-980.
17. Nosál' R., Jančinová V., Danihelová E. Chloroquine: a multipotent inhibitor of human platelets in vitro. Thromb. Res. 98:2000;411-421.
18. Jančinová V., Drábiková K., Nosál' R., Danihelová E. Platelet-dependent modulation of polymorphonuclear leukocyte chemiluminescence. Platelets. 11:2000;278-285.
19. Hampton M.B., Kettle A.J., Winterbourn C.C. Inside the neutrophil phagosome: oxidants, myeloperoxidase, and bacterial killing. Blood. 92:1998;3007-3017.
20. Dahlgren C., Karlsson A. Respiratory burst in human neutrophils. J. Immunol. Methods. 232:1999;3-14.
21. DeChatelet L.R., Long G.D., Shirley P.S., Bass D.A., Thomas M.J., Henderson F.W.et al. Mechanism of the luminol-dependent chemiluminescence of human neutrophils. J. Immunol. 129:1982;1589-1593.
22. Bengtsson T., Zalavary S., Stendahl O., Grenegard M. Release of oxygen metabolites from chemoattractant-stimulated neutrophils is inhibited by resting platelets: role of extracellular adenosine and actin polymerization. Blood. 87:1996;4411-4423.
23. Herbertsson H., Bengtsson T. Role of platelets and the arachidonic acid pathway in the regulation of neutrophil oxidase activity. Scand. J. Clin. Lab. Invest. 61:2001;641-650.
24. Aziz K.A., Zuzel M. Regulation of polymorphonuclear leukocyte function by platelets. Saudi Med. J. 22:2001;526-530.
25. Carulli G., Barsotti G., Cupisti A., Minnucci S., Gianfaldoni M.L., Agostini B.et al. Platelet-neutrophil interactions in uremic patients: effects on neutrophil superoxide anion production and chemiluminescence. Nephron. 69:1995;248-252.
26. Labro M.T., Babin-Chevaye C. Effects of amodiaquine, chloroquine, and mefloquine on human polymorphonuclear neutrophil function in vitro. Antimicrob. Agents Chemother. 32:1988;1124-1130.
27. Styrt B., Klempner M.S. Inhibition of neutrophil oxidative metabolism by lysosomotropic weak bases. Blood. 67:1986;334-342.
28. Neal T.M., Vissers M.C.M., Winterbourn C.C. Inhibition by nonsteroidal anti-inflammatory drugs of superoxide production and granule enzyme release by polymorphonuclear leukocytes stimulated with immune complexes of formyl-methionyl-leucyl-phenylalanine. Biochem. Pharmacol. 36:1987;2511-2517.
29. Schuff-Werner P., Splettstösser W. Antioxidative properties of serotonin and the bactericidal function of polymorphonuclear phagocytes. Adv. Exp. Med. Biol. 467:1999;321-325.
30. Vial T., Tedone R., Patriarca C., Descotes J. Effect of serotonin on the chemiluminescence response of rat peripheral blood leucocytes. Int. J. Immunopharmacol. 17:1995;813-819.
31. Huether G., Fettkötter I., Keilhoff G., Wolf G. Serotonin acts as a radical scavenger and is oxidized to a dimer during the respiratory burst of activated microglia. J. Neurochem. 69:1997;2096-2101.
32. Costa J.L., Fay D.D., Kirk K.L. Quinacrine and other basic amines in human platelets: subcellular compartmentation and effect on serotonin. Res. Commun. Chem. Pathol. Pharmacol. 43:1984;25-42.
33. Nosál' R., Ericsson Ö., Sjöqvist F., Ďurišová M. Distribution of chloroquine in human blood fractions. Methods Find. Exp. Clin. Pharmacol. 10:1988;581-587.
34. Huether G., Schuff-Werner P. Platelet serotonin acts as a locally releasable antioxidant. Filippini G.A., Costa C.V.L., Bertazzo A. Recent advances in tryptophan research. Tryptophan and serotonin pathways. 1996;299-306 Plenum, New York.
35. Takahashi R., Edashige K., Sato E.F., Inoue M., Matsuno T., Utsumi K. Luminol chemiluminescence and active oxygen generation by activated neutrophils. Arch. Biochem. Biophys. 285:1991;325-330.
36. Salman-Tabcheh S., Guérin M.C., Torreilles J. Potential role of the peroxidase-dependent metabolism of serotonin in lowering the polymorphonuclear leukocyte bactericidal function. Free Radic. Res. 24:1996;61-68.
37. French J.K., Hurst N.P., O'Donnell M.L., Betts W.H. Uptake of chloroquine and hydroxychloroquine by human blood leucocytes in vitro: relation to cellular concentrations during antirheumatic therapy. Ann. Rheum. Dis. 46:1987;42-45.
38. Salmon D., Verdier F., Malhotra K., Pussard E., Clavier F., Le Bras J.et al. Absence of effect of chloroquine in vivo on neutrophil oxidative metabolism in human subjects. J. Antimicrob. Chemother. 25:1990;367-370.
39. Sullivan G.W., Sarembock I.J., Linden J. The role of inflammation in vascular diseases. J. Leukoc. Biol. 67:2000;591-602.
40. Siminiak T., Flores N.A., Sheridan D.J. Neutrophil interactions with endothelium and platelets: possible role in the development of cardiovascular injury. Eur. Heart J. 16:1995;160-170.
41. Wallace D.J. The use of chloroquine and hydroxychloroquine for non-infectious conditions other than rheumatoid arthritis or lupus: a critical review. Lupus. 5(Suppl. 1):1996;S59-S64.